Biomimetic, ROS-detonable nanoclusters — A multimodal nanoplatform for anti-restenotic therapy-Reference-Cited by-同舟云学术

Biomimetic, ROS-detonable nanoclusters — A multimodal nanoplatform for anti-restenotic therapy

Published:2021-10 Issue: Volume:338 Page:295-306
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Zhao Yi,Shirasu Takuro,Yodsanit Nisakorn,Kent Eric,Ye Mingzhou,Wang Yuyuan,Xie Ruosen,Gregg Alexander Christopher,Huang Yitao,Kent K. Craig,Guo Lian-Wang,Gong Shaoqin,Wang Bowen

Funder

National Institute of Health

National Institutes of Health

Uehara Memorial Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference72 articles.

1. Paclitaxel-induced Arterial Wall toxicity and inflammation: part 2—long-term tissue response in a minipig model;Stampfl;J. Vasc. Interv. Radiol.,2009

2. Endovascular intervention for peripheral artery disease;Thukkani;Circ. Res.,2015

3. Inflammation and restenosis in the stent era;Welt;Arterioscler. Thromb. Vasc. Biol.,2002

4. Intimal hyperplasia: slow but deadly;Mills;Perfusion,2012

5. Treatment strategies for in-stent restenosis in peripheral arterial disease: a systematic review;Hajibandeh;INTERACT CARDIOV TH,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery;Journal of Controlled Release;2024-09

2. Emerging platelet-based drug delivery systems;Biomedicine & Pharmacotherapy;2024-08

3. The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia;JVS-Vascular Science;2024-08

4. Targeted NAD⁺Delivery for Intimal Hyperplasia and Re-endothelialization: A Novel Anti-restenotic Therapy Approach;2024-02-23

5. Navigating the landscape: Prospects and hurdles in targeting vascular smooth muscle cells for atherosclerosis diagnosis and therapy;Journal of Controlled Release;2024-02